Last10K.com

America Great Health (AAGH) SEC Filing 10-Q Quarterly report for the period ending Friday, March 31, 2017

America Great Health

CIK: 1098009 Ticker: AAGH
Document And Entity Information - shares
9 Months Ended
Mar. 31, 2017
May 15, 2017
Document and Entity Information [Abstract]  
Entity Registrant NameAmerica Great Health 
Document Type10-Q 
Current Fiscal Year End Date--06-30 
Entity Common Stock, Shares Outstanding 20,236,021,800
Amendment Flagfalse 
Entity Central Index Key0001098009 
Entity Current Reporting StatusYes 
Entity Voluntary FilersNo 
Entity Filer CategorySmaller Reporting Company 
Entity Well-known Seasoned IssuerNo 
Document Period End DateMar. 31, 2017 
Document Fiscal Year Focus2017 
Document Fiscal Period FocusQ3 

View differences made from one quarter to another to evaluate America Great Health's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by America Great Health.

Continue

Assess how America Great Health's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

America Great Health's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (parentheticals)
Condensed Consolidated Statement Of Shareholders' Equity (deficit) (unaudited)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Operations
Accounting Policies, By Policy (policies)
Document And Entity Information
Note 1 - Basis Of Presentation
Note 1 - Basis Of Presentation (details)
Note 2 - Summary Of Significant Accounting Policies
Note 2 - Summary Of Significant Accounting Policies (details)
Note 3 - Discontinued Operations
Note 3 - Discontinued Operations (details)
Note 3 - Discontinued Operations (details) - Disposal Groups, Including Discontinued Operations
Note 3 - Discontinued Operations (details) - Disposal Groups, Including Discontinued Operations
Note 3 - Discontinued Operations (details) - Disposal Groups, Including Discontinued Operations (parentheticals)
Note 3 - Discontinued Operations (tables)
Note 4 - Related Party Transactions
Note 4 - Related Party Transactions (details)
Note 4 - Related Party Transactions (details) - Schedule Of Related Party Transactions
Note 4 - Related Party Transactions (details) - Schedule Of Related Party Transactions (parentheticals)
Note 4 - Related Party Transactions (tables)
Note 5 - Short-term Loans Payable
Note 5 - Short-term Loans Payable (details)
Note 6 - Convertible, Redeemable Preferred Stock
Note 6 - Convertible, Redeemable Preferred Stock (details)
Note 7 - Shareholders' Deficit
Note 7 - Shareholders' Deficit (details)
Note 8 - Non-controlling Interest
Note 8 - Non-controlling Interest (details)
Note 9 -subsequent Events

Material Contracts, Statements, Certifications & more

America Great Health provided additional information to their SEC Filing as exhibits

Ticker: AAGH
CIK: 1098009
Form Type: 10-Q Quarterly Report
Accession Number: 0001185185-17-001248
Submitted to the SEC: Mon May 22 2017 5:29:29 PM EST
Accepted by the SEC: Mon May 22 2017
Period: Friday, March 31, 2017
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aagh/0001185185-17-001248.htm